TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014
TCL Archive In Brief: Hammer Reappointed chairman; Wyngaarden Names Ferguson of Baylor As OMAR Director July 29, 1988